New patient experience: first-visit economics

Spend $50.60 to put one general-dentistry lead in the pipeline, and by the time that person actually sits in your chair you've paid about $108 for the privilege. Then your team has roughly twenty minutes to decide whether that $108 turns into $630 of accepted treatment or $1,050, because the 2026 Catalyst Index pooled practice data from Henry Schein One puts industry-average case acceptance near 45% while the top 10% of practices run around 75%. Same lead cost. Same chair. A 30-point spread in what the visit is worth.

So here's our thesis, and plenty of owners will fight it: your new-patient count is a vanity metric, and if you're sitting at average case acceptance, every additional dollar of ad spend is making your practice worse, not bigger. We'd freeze the marketing budget at today's level and spend the next quarter rebuilding the first visit instead. Growth-minded owners hate this. They'll tell you volume compounds, that a bigger top of funnel fixes everything downstream. It doesn't. It just raises the cost of a conversion problem you haven't solved.

A $50.60 Lead Becomes a $108 Patient Before Anyone Sits Down

Start with what traffic actually costs. Delmain's rolling 120-day benchmark across 187 dental Google Ads campaigns shows cost per tracked lead ranging from $7.64 for branded searches to $50.60 for general dentistry and $212.63 for Invisalign. Those are lead costs, not patient costs, and the difference between the two is where most practice budgets quietly bleed out.

Run 60 general-dentistry leads a month and you've spent $3,036.

Assume a competent front desk converts 55% of tracked leads into a booked appointment: 33 appointments.

Now apply attrition. The cleanest peer-reviewed read on dental no-shows comes from Oliveira and colleagues in the International Journal of Dentistry, who analyzed 7,379 visits at an academic dental clinic and found a 14.3% overall no-show rate. That's a pediatric academic setting, not your private general practice, so treat it as a directional floor rather than your number. Apply it anyway and 33 booked appointments become about 28 arrivals.

Cost per patient who actually shows up: $108.43.

That's the real acquisition price, and it's already 2.1 times the number most owners quote when they talk about their marketing cost per patient. Every leak between the click and the chair multiplies the lead cost rather than adding to it.

The 30-Point Gap Is Worth $141,120 a Year

Here's the scenario that matters. Take those 28 arriving new patients a month. Say your comprehensive exam produces an average diagnosed treatment plan of $1,400 per new patient, which is a reasonable modeled figure for a general practice doing full-mouth series, perio charting and a real risk conversation rather than a cleaning and a wave goodbye.

At the industry-average 45% acceptance rate, each new patient converts to $630 of accepted treatment.

Across 28 patients, that's $17,640 a month in accepted care from new-patient flow.

At the top-decile 75% rate, each patient converts to $1,050.

Across the same 28 patients, $29,400.

The spread is $11,760 a month, or $141,120 a year, on identical marketing spend and identical chair capacity.

Now price the alternative. Suppose you refuse to touch the first visit and decide to buy your way to the same $11,760. At 45% acceptance and $630 per patient, you need 18.7 more arriving new patients every month.

Back that out through a 14.3% no-show rate and you need 21.8 more booked appointments.

Back that out through 55% lead-to-booking and you need 39.6 more leads.

At $50.60 a lead, that's $2,004 a month in additional ad spend, $24,048 a year.

And the cash is the easy part. You also need roughly 19 additional new-patient slots a month, which at 60 minutes each is 19 hours of hygiene and doctor exam time you have to staff, equip and fill. You've added payroll, added chair pressure and added a $24,048 recurring expense to generate revenue the top-decile practice gets for free out of the same schedule it already runs.

Our view: that's not growth, it's a tax on a broken handoff. We wouldn't approve that budget increase. We'd put the $24,048 into whatever gets acceptance from 45% to 60%, which on this model is worth $70,560 a year, and we'd take the chair time back as a bonus.

What Most Owners Get Wrong: Buying Volume to Fix a Conversion Problem

The specific mistake, and it's made most often by owners two to six years into ownership who've just paid off the practice loan and finally have discretionary cash, is treating the marketing budget as the only growth control they own. It's the most legible dial on the dashboard. You add $2,000 a month, leads go up next week, and the production chart twitches in the right direction. Rebuilding the first visit shows no movement for sixty days and requires telling a long-tenured team member that the way they've presented treatment for nine years is costing the practice six figures.

Owners pick the dial. We understand why. But here's what it looks like from the outside: a practice paying $108 per arrival, diagnosing properly, and then handing the patient a printed plan with a "call us when you're ready" at the front desk, which is the single most expensive sentence in dentistry. The plan doesn't fail because the patient can't afford it. It fails because nobody scheduled the next visit while the patient was still in the building.

The second version of the mistake is subtler: judging the first visit by the hygiene fee it generated. A new-patient exam that collects $280 and produces zero scheduled treatment looks fine on the day sheet and is a $750 loss against what it should have produced. Day-sheet thinking is why the gap persists.

Why That Invisalign Click Costs $1,003 or $602

The high-ticket categories are where acceptance math turns brutal. An Invisalign lead at $212.63, run through 55% booking, 85.7% arrival and 45% acceptance, costs you $1,002 per started case.

Run the identical ad through a 75% acceptance practice and the same started case costs $601.

Nobody won an auction there. One practice simply converts the consult and the other sends a quote. If you're bidding on clear-aligner keywords at average acceptance, you're paying a $401 penalty per case for a conversation your competitor is having better. We'd pull the aligner campaigns entirely until the consult script and the same-day financing decision are fixed, then turn them back on. The clicks will still be there.

The No-Show Line Item Nobody Books

At a 14.3% rate against 33 booked new-patient appointments, you're losing roughly 4.7 arrivals a month. The lead cost alone is $238 a month of pure waste, $2,856 a year.

The chair time is the bigger number. Value an empty 60-minute new-patient block at $250 of foregone production and those 4.7 holes cost $1,175 a month, $14,100 a year.

The Oliveira data also breaks out something useful for anyone with a family-heavy patient base: adolescents aged 12 to 17 no-showed at 24%, against 6.8% for children aged 0 to 7. If your schedule leans teen, your attrition assumption is wrong and your acquisition cost per arrival is materially higher than the model above. We'd stop confirming teen appointments through the parent's voicemail and start double-confirming the day before with a reply-required text.

One more structural point worth holding onto. CDC/NCHS FastStats reports that 65.5% of adults 18 and over had a dental exam or cleaning in the past year as of 2023, which means about a third of adults did not. Many of your new patients are arriving after a multi-year gap carrying deferred need. Their diagnosed plans are larger than your recall base's, which is exactly why a 45% acceptance rate does more damage on new patients than anywhere else in the practice.

Score the Visit, Not the Month

Three numbers belong on a weekly report, and new-patient count is not one of them. First: diagnosed dollars per new patient, which tells you whether your exam is actually comprehensive or just a screening with better lighting. Second: percentage of new patients who leave with a next clinical appointment on the books, not a plan in hand. Third: 30-day plan conversion, measured in dollars accepted against dollars diagnosed, by provider.

Track those by provider and the 30-point gap stops being an industry statistic and becomes a name. That's uncomfortable, which is the point. Nobody fixes an average.

Four Moves Before Friday

Pull last month's new-patient list and calculate dollars diagnosed against dollars accepted; if you land near 45%, you've just found $141,120 a year hiding in your existing schedule. Change one rule this week: nobody leaves the building without a scheduled next appointment, and the treatment coordinator does the scheduling chairside, not at checkout. Pause your highest-cost-per-lead campaign for 30 days and redirect nothing, just hold the cash and watch whether production moves. Then double-confirm every teen appointment with a reply-required text the day prior.

What we're tracking next: whether that 45% industry average holds as same-visit treatment starts spread through group practices, and whether the acceptance gap narrows or widens over the next four quarters. What would change our mind on the marketing freeze: a practice holding 70%-plus acceptance while scaling spend. At that point more leads is exactly the right answer, and we'd say so. You're not buying patients, you're buying appointments, and the chair decides whether they were worth the price.

If you want to know what a new patient has to produce just to cover your fixed costs, that depends entirely on your overhead load, and most owners are working from a number that's two years stale. Pull your last twelve months of expenses and run your own numbers through the overhead calculator; it will tell you the break-even production per chair hour that every first visit is being measured against, whether you've been measuring it or not.